SJ830599

CAS No. 2215098-23-8

SJ830599( SJ 830599 )

Catalog No. M13530 CAS No. 2215098-23-8

SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SJ830599
  • Note
    Research use only, not for human use.
  • Brief Description
    SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1.
  • Description
    SJ830599 is a modest selective BRD2-BD2 inhibitor with IC50 of 0.61 uM, 3.3-fold selectivity over BRD2-BD1; demonstrates cytotoxicity against several pediatric cancer cell lines with EC50 values (HD-MB03 EC50=480 nM) comparable to BET inhibitor (BETi) clinical candidates.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SJ 830599
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2215098-23-8
  • Formula Weight
    356.422
  • Molecular Formula
    C20H24N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Isopropyl ((2S,4R)-1-acetyl-6-(furan-2-yl)-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shadrick WR, et al. Bioorg Med Chem. 2018 Jan 1;26(1):25-36.
molnova catalog
related products
  • HJB-97

    A potent BET bromodomian inhibitor with IC50 of 3-7 nM for BRD2/3/4 BD1 and BD2.

  • GS-626510

    GS-626510 (GS-6510, GS 6510, GS 626510) is a?novel BET family bromodomains inhibitor with Kd of 0.5-2.8 nM for BRD2/3/4, and BRDT.

  • GNE-781

    GNE-781 (GNE781) is a potent, selective, non-CNS penetrant, orally active CBP/p300 bromodomain inhibitor.